Nootropics Market Size To Reach $13.29 Billion By 2033

Nootropics Market Growth & Trends

The global nootropics market size is expected to reach USD 13.29 billion by 2033, registering a CAGR of 12.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. The global market has witnessed increased growth in the last few years, which is expected to continue over the forecast period. This growth is driven by the increasing awareness among consumers regarding the cognitive health benefits of nootropics and their desire to improve mental performance. As the global population ages, there is a growing interest in products that support brain health, and nootropics are seen as a viable option. In addition, the prevalence of stress and mental health concerns is propelling individuals to explore cognitive enhancers.

Nootropic capsules have higher penetration as they are easy to take and do not require any preparation or mixing. Consumers can simply swallow a capsule with water, making it a convenient option for those with busy lifestyles. Capsules provide precise and consistent dosages of nootropic ingredients. This is particularly important when it comes to cognitive enhancers, as accurate dosing is crucial for achieving the desired effects. Capsules are a common form of pharmaceuticals and dietary supplements, which can enhance the perceived credibility of nootropic products.

Nootropics manufacturers are increasingly prioritizing natural ingredients in response to the growing consumer demand for such products. For instance, in October 2021, XITE, a nootropic energy drinks brand, launched a nootropic vegan protein bar to appeal to the growing consumer base of mind health-conscious consumers. The bars are packed with nootropics, such as caffeine, L-theanine, and ashwagandha, which are claimed to improve cognitive function, focus, and energy level. Similarly, in April 2019, Gaia Herbs launched new vegan supplements called Bacopa made using Bacopa; Nootropic Focus made with saffron, lemon balm, and spearmint; and Agile Mind made with Bacopa, gingko, and turmeric.

 Request a free sample copy or view report summary: Nootropics Market Report

Nootropics Market Report Highlights

• The nootropics in capsules/ tablets form accounted for the largest revenue share of 44.0% in 2025, primarily driven by convenience and ease of consumption, the capsules and tablets segment in the nootropics market is experiencing rapid growth.

• The nootropics sold through offline channels held the largest revenue share of 75.8% in 2025, driven by increasing consumer trust and the desire for in-person product experience, nootropic sales through offline channels are growing rapidly.

• The nootropics market in North America accounted for the largest market share of 40.9% in 2025. In North America, strong consumers focus on cognitive wellness and preventative health is fueling the demand for nootropics

Nootropics Market Segmentation

Grand View Research has segmented the global nootropics market based on form, distribution channel, and region:

Nootropics Form Outlook (Revenue, USD Million, 2021 - 2033)

• Capsules/Tablets

• Powder

• Drinks

• Others

Nootropics Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Online

• Offline

Nootropics Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • India

  • China

  • Australia & New Zealand

  • South Korea

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa

List Of Key Players Nootropics Market

• Onnit Labs, Inc.

• Reckitt Benckiser Group PLC

• Mind Lab Pro

• TruBrain

• Nooflux

• Zhou Nutrition

• Nootropics Depot

• Neutonic

• Amway Corp.

• Natural Stacks